Genetic tools such as microarray and next-generation sequencing have initiated a new era
for the diagnosis and management of patients with disorders of sex development (DSDs).
These tools supplement the traditional approach to the evaluation and care of infants,
children, and adolescents with DSDs. These tests can detect genetic variations known to be
associated with DSDs, discover novel genetic variants, and elucidate novel mechanisms of
gene regulation. Herein, we discuss these tests and their role in the management of patients …